Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Moodys
UBS
Express Scripts
Covington

Generated: May 22, 2019

DrugPatentWatch Database Preview

sanctura xr Drug Profile

« Back to Dashboard

When do Sanctura Xr patents expire, and when can generic versions of Sanctura Xr launch?

Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has fifteen patent family members in eleven countries.

The generic ingredient in SANCTURA XR is trospium chloride. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.

Drug patent expirations by year for sanctura xr
Synonyms for sanctura xr
[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-oxidanyl-2,2-diphenyl-ethanoate chloride
1001323-19-8
10405-02-4
1E6682427E
2-hydroxy-2,2-diphenylacetic acid [(1S,5R)-3-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]yl] ester chloride
3-((hydroxydiphenylacetyl)oxy)-spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium chloride
3alpha-Hydroxyspiro(1alphaH,5alphaH-nortropane-8,1'-pyrrolidinium) chloride benzilate
8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride
A800884
AB0000782
AB2000646
AC-4235
AC1NR4ST
AKOS015833209
API0004533
AS Xvii
Azoniaspiro Compound XVII
Azoniaspiro(3-alpha-benziloyloxy-nortropan-8,1'-pyrrolidine)-chloride
B-1868
BC209629
BCP0726000291
BCP23426
CAS-10405-02-4
CHEMBL3084748
Chlorure de trospium
Chlorure de trospium [INN-French]
Cloruro de trospio
Cloruro de trospio [INN-Spanish]
CS-2572
DSSTox_CID_3724
DSSTox_GSID_23724
DSSTox_RID_77166
DTXSID7023724
EINECS 233-875-4
FT-0636699
HMS3656C16
HY-B0461
IP631
Keptan
MolPort-005-935-494
NCGC00167438-01
NCGC00167438-02
Relaspium
RVCSYOQWLPPAOA-QKYUOBHYSA-M
s2549
Sanctura
Santura
SCHEMBL13836646
SCHEMBL25785
Spasmex
Spasmo 3
Spasmo-lyt
Spiro (8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha, 3beta, 5alpha)
Spiro(1-alpha-H,5-alpha-H-nortropane-8,1'-pyrrolidinium), 3-alpha-hydroxy-, chloride, benzilate
Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium, 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha,3beta,5alpha)-
Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5);Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5)
ST24050330
SW219146-1
Tox21_112442
Tox21_112442_1
Trospii chloridum
Trospii chloridum [INN-Latin]
Trospium (chloride)
trospium chloride
Trospium chloride (Sanctura)
Trospium chloride [USAN:USP:INN:BAN:JAN]
Trospium Cl
Trospiumchlorid
UNII-1E6682427E
Uraplex
W-108827

US Patents and Regulatory Information for sanctura xr

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Allergan SANCTURA XR trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 022103-001 Aug 3, 2007 DISCN Yes No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for SANCTURA XR
Drugname Dosage Strength RLD Date
➤ Subscribe Extended-release Capsules 60 mg ➤ Subscribe ➤ Sign Up

Premature patent expiration for: SANCTURA XR

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
➤ Sign Up SANCTURA XR ➤ Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Harvard Business School
Teva
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.